BBB Therapeutics Alternatives & Competitors

12 companies similar to BBB Therapeutics — Combines existing drugs with it's proprietary for enhanced drug delivery across...

Raptor Pharmaceuticals

Embarking on a journey to better health through innovative biotechnology solutions for bra...

Post-IPO Equity $222.89M

Biopharma Biotechnology +1

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Alector

We are on a mission to make brain disorders history.

141 IPO $495.50M

South San Francisco, Unit...

Biotechnology Health Care +2

Quince Therapeutics

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...

25 Post-IPO Equity

South San Francisco, Unit...

Biotechnology Health Care +1

Track all BBB Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Syntara

Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fi...

58 Post-IPO Equity $1.39M

Australia

Biotechnology Health Care +1

Compare

Endevica Bio

Reversing cachexia and improving quality of life in cancer patients. Phase 1 trial underwa...

20 Series B $14.00M

Columbia, United States

Biotechnology Health and Wellness +1

Cantabio Pharmaceuticals, Inc.

Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...

13 Grant

Sunnyvale, United States

Biotechnology Pharmaceutical

Tvardi Therapeutics

Breakthrough Medicines for Cancer, Chronic Inflammation & Fibrosis

18 Series B $81.42M

Houston, United States

Biotechnology Health Care +1

Pacylex Pharmaceuticals, Inc.

A new target in cancer care - triggering selective lethality with a new class of drugs.

9 Grant $12.30M

Edmonton, Canada

Biotechnology Health Care +3

Molecure

Fate can be altered.

85 Post-IPO Secondary $50.00M

Warsaw, Poland

Biopharma Biotechnology +1

Compare

Wize Pharma

Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment o...

2 Post-IPO Equity $7.50M

Hod Hasharon, Israel

Biopharma Biotechnology +2

Biodexa Pharmaceuticals PLC

Advancing Medicines for a Brighter Future

25 Post-IPO Equity $36.56M

Cardiff, United Kingdom

Biopharma Biotechnology +2

About BBB Therapeutics

BBB Therapeutics, founded in 2003 and headquartered in The Netherlands, is a clinical stage biotechnology company that has carved a niche in developing treatments for critical brain disorders, including brain cancer and neuroinflammatory diseases. The company leverages its proprietary G-TechnologyĂ‚Ĺ˝ platform to enhan...

Taxonomy

Clinical Stage, Brain Disorders, Brain Cancer, Neuroinflammatory Diseases, Drug Development, G-Technology, Drug Delivery, Blood-brain Barrier, Clinical Trials, 2B3-101, 2B3-201, Phase IIa Trial, Phase I Clinical Study, Treatment

Frequently Asked Questions

Companies similar to BBB Therapeutics include Raptor Pharmaceuticals, Cavion, Alector, Quince Therapeutics, Syntara. They work in Biotechnology and Pharmaceutical and share BBB Therapeutics's focus on drug development, clinical trials and clinical stage.

Bounce Watch lists 12 companies that share BBB Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches BBB Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

BBB Therapeutics Profile Raptor Pharmaceuticals Alternatives Cavion Alternatives Alector Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BBB Therapeutics on 23 Feb 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.